Can Marks and Spencer regain its sparkle, what does the push to fund small-caps to develop antibiotics mean for drug development minnows and more in this week's Companies & Markets Show with editor John Hughman and guests.
Can Marks and Spencer regain its sparkle, what does the push to fund small-caps to develop antibiotics mean for drug development minnows and more in this week's Companies & Markets Show with editor John Hughman and guests.